__NUXT_JSONP__("/drugs/Imalumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1430205-07-4",chebiId:b,chemicalFormula:b,definition:"A human, recombinant monoclonal antibody (MoAb) against macrophage migration inhibitory factor (MIF), with potential immunomodulating, anti-inflammatory and antineoplastic activities. Upon intravenous administration, imalumab binds to MIF, blocking its activity and preventing the MIF-mediated secretion of certain cytokines, including interleukin-1 beta and tumor necrosis factor-alpha. This may lead to an inhibition of cancer cell proliferation in MIF-overexpressing tumor cells. MIF, a pro-inflammatory cytokine overexpressed in some cancers, plays a key role in inflammation, immune responses and cancer cell proliferation.",fdaUniiCode:"22F97PC79G",identifier:"C104260",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["BAX-69","BAX069","BAX69","IMALUMAB",a,"Immunoglobulin G1-kappa, Anti-(Homo sapiens MIF (Macrophage Migration Inhibitory Factor, Glycosylation-inhibiting Factor, GlIF, GIF)), Homo sapiens Monoclonal Antibody"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FImalumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Imalumab","","2021-10-30T13:17:33.613Z")));